REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,718,767 | -54.8% | 4,160,311 | -0.2% | 0.35% | -33.5% |
| Q2 2023 | $105,488,081 | -21.4% | 4,167,842 | 0.0% | 0.53% | -39.0% |
| Q1 2023 | $134,246,191 | +50.0% | 4,167,842 | -14.0% | 0.87% | +22.3% |
| Q4 2022 | $89,505,765 | -25.7% | 4,848,633 | +8.7% | 0.71% | -7.2% |
| Q3 2022 | $120,467,000 | +179.6% | 4,461,747 | +43.1% | 0.77% | +203.6% |
| Q2 2022 | $43,078,000 | -10.1% | 3,117,052 | +26.9% | 0.25% | +17.1% |
| Q1 2022 | $47,902,000 | +29.9% | 2,456,497 | +8.7% | 0.22% | +56.5% |
| Q4 2021 | $36,878,000 | -24.1% | 2,259,700 | +29.6% | 0.14% | -30.3% |
| Q3 2021 | $48,560,000 | +41.9% | 1,742,997 | +50.9% | 0.20% | +32.9% |
| Q2 2021 | $34,226,000 | +6.0% | 1,154,734 | 0.0% | 0.15% | -25.5% |
| Q1 2021 | $32,275,000 | -1.4% | 1,154,734 | 0.0% | 0.20% | +1.0% |
| Q4 2020 | $32,725,000 | – | 1,154,734 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |